Literature DB >> 19914335

Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells.

Bo Su1, Xinglong Wang, Hyoung-Gon Lee, Massimo Tabaton, George Perry, Mark A Smith, Xiongwei Zhu.   

Abstract

Tau hyperphosphorylation appears to be a critical event leading to abnormal aggregation and disrupted function of tau in affected neurons in Alzheimer's disease (AD). As a prominent early event during AD pathogenesis, oxidative stress is believed to contribute to tau phosphorylation and the formation of neurofibrillary lesions. However, acute oxidative stress has disparate effects on tau phosphorylation. Given the chronic nature of AD, in this study, we aimed to determine the long-term effect of oxidative stress on tau phosphorylation. In this regard, we established a novel in vitro model of chronic oxidative stress through inhibition of glutathione (GSH) synthesis with BSO. We confirmed that these cells were under a chronic mild oxidative stress by looking at oxidative response, the induction of heme oxygenase 1 (HO-1) without neuronal death. Chronic oxidative stress increased levels of tau phosphorylated at PHF-1 epitope (serine 399/404) in a time-dependent manner. Our data further suggest that increased activity of JNK and p38 and decreased activity of PP2A are likely involved in chronic oxidative stress-induced tau phosphorylation. In conclusion we suggest that chronic oxidative stress contributes to increased tau phosphorylation in vitro and could play a critical role in neurofibrillary pathology in vivo. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914335     DOI: 10.1016/j.neulet.2009.11.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  46 in total

1.  Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.

Authors:  Olayemi Joseph Olajide; Nnaemeka Tobechukwu Asogwa; Blessing Oluwapelumi Moses; Christiana Bidemi Oyegbola
Journal:  Metab Brain Dis       Date:  2017-04-13       Impact factor: 3.584

Review 2.  A Cerebrovascular Hypothesis of Neurodegeneration in mTBI.

Authors:  Danielle R Sullivan
Journal:  J Head Trauma Rehabil       Date:  2019 May/Jun       Impact factor: 2.710

3.  Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease.

Authors:  Kang-Woo Lee; Joo-Young Im; Jong-Min Woo; Hilary Grosso; Yoon-Seong Kim; Ana Clara Cristovao; Patricia K Sonsalla; David S Schuster; Marla M Jalbut; Jose R Fernandez; Michael Voronkov; Eunsung Junn; Steven P Braithwaite; Jeffry B Stock; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 4.  Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.

Authors:  Mingxue Song; Xiulan Zhao; Fuyong Song
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

5.  Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.

Authors:  Julia E Gamache; Lisa Kemper; Elizabeth Steuer; Kailee Leinonen-Wright; Jessica M Choquette; Chris Hlynialuk; Kellie Benzow; Keith A Vossel; Weiming Xia; Michael D Koob; Karen H Ashe
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

Review 6.  Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Brain Res       Date:  2011-07-31       Impact factor: 3.252

7.  Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.

Authors:  Sudhir Kshirsagar; Neha Sawant; Hallie Morton; Arubala P Reddy; P Hemachandra Reddy
Journal:  Pharmacol Res       Date:  2021-11-08       Impact factor: 7.658

8.  A new link to mitochondrial impairment in tauopathies.

Authors:  Kathrin L Schulz; Anne Eckert; Virginie Rhein; Sören Mai; Winfried Haase; Andreas S Reichert; Marina Jendrach; Walter E Müller; Kristina Leuner
Journal:  Mol Neurobiol       Date:  2012-07-31       Impact factor: 5.590

Review 9.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 10.  Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Antioxid Redox Signal       Date:  2018-05-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.